Levicept
is an England-based biotechnology company that researches and develops novel therapeutics for the treatment of chronic pain... Read moreLevicept
is an England-based biotechnology company that researches and develops novel therapeutics for the treatment of chronic pain... Read more
News
Sep 02, 2026
GlobeNewswire
Press Release: Levicept : Levicept Announces Attendance at Cantor and Jefferies Global Healthcare Conferences
Jun 03, 2026
GlobalNewswire
Press Release: Levicept : Levicept to Present Data Suggesting LEVI-04 May Modify Disease in Osteoarthritis at EULAR 2026
Apr 24, 2026
GlobalNewswire
Press Release: Levicept : Levicept to Present Data from Phase II study of LEVI-04 at OARSI 2026 World Congress on Osteoarthritis
Mar 30, 2026
GlobalNewswire
Press Release: Levicept : Levicept Announces The Lancet Publication of LEVI-04 Phase II Clinical Trial Results, Showing Significant Reduction in Pain and Symptoms of Osteoarthritis
Jan 20, 2026
StreetInsider
Press Release: Levicept : Levicept Announces FDA Acceptance of IND Application for LEVI-04, a Potentially Disease-Modifying Treatment for Osteoarthritis
Sep 25, 2025
StreetInsider
Press Release: Levicept : Levicept to Present Key New Data from Phase II Trial of LEVI-04, a Novel Neurotrophin-3 Inhibitor, at ACR Convergence 2025
Jun 12, 2025
PharmaTimes
Levicept: Levicept presents new LEVI-04 data at EULAR
Aug 09, 2024
PMLiVE
Levicept: Levicept's NT-3 inhibitor shows promise in moderate-to-severe osteoarthritis
Aug 06, 2024
Endpoints News
Levicept: Eliot Forster's pain biotech unveils Phase 2 data in degenerative joint disease
Dec 13, 2023
Life Care News
Levicept: Levicept Completes Recruitment in Phase II Clinical Trial
